Travelit Tablet 50 mg is an antihistamine commonly used to treat nausea, vomiting, and dizziness associated with motion sickness and vertigo. It is a first-generation antihistamine with sedative properties that help to manage symptoms related to inner ear disorders and travel-related nausea.
Travelit Tablet 50 mg is primarily used for:
| Brand Name | Travelit |
|---|---|
| Type | Tablet |
| Weight | 50 mg |
| Generic | Cyclizine Hydrochloride |
| Manufacturer | Sharif Pharmaceuticals Ltd. |
| Available in | English বাংলা |
Travelit Tablet 50 mg works by blocking histamine H1 receptors in the brain, particularly in the vestibular system, which helps to reduce symptoms of nausea and dizziness. It also has anticholinergic properties that contribute to its antiemetic effects.
The onset of action for Travelit Tablet 50 mg is typically within 30 minutes to 1 hour after oral administration. Its effects generally last for about 4 to 6 hours, making it effective for short-term management of symptoms.
Travelit Tablet 50 mg is well absorbed from the gastrointestinal tract following oral administration. Peak plasma concentrations are usually reached within 2 to 3 hours.
The drug is metabolized primarily in the liver. It is excreted mainly in the urine as metabolites, with a small amount being eliminated in the feces.
The typical dosage of Travelit Tablet 50 mg is:
Travelit Tablet 50 mg is administered orally in the form of tablets or liquid. It is best taken with water and can be taken with or without food.
Common side effects include:
Toxicity may occur with excessive doses and can lead to symptoms such as severe drowsiness, agitation, hallucinations, and seizures. Immediate medical attention is required in case of overdose.
Use Travelit Tablet 50 mg with caution in patients with a history of glaucoma, urinary retention, or respiratory conditions such as asthma. It may impair the ability to perform tasks requiring mental alertness, such as driving.
Travelit Tablet 50 mg may interact with other central nervous system depressants, such as alcohol, benzodiazepines, and opioids, potentially enhancing sedative effects. Inform your healthcare provider of all medications you are taking.
Use with caution in patients with liver impairment, as it may affect the metabolism of the drug. It should also be used with care in patients with cardiovascular disease due to potential anticholinergic effects.
Interactions may occur with:
There are no specific food interactions with Travelit Tablet 50 mg. However, it is advisable to avoid alcohol and other sedatives while taking this medication.
Travelit Tablet 50 mg is classified as Category B by the FDA, indicating that it is generally considered safe during pregnancy but should be used only if clearly needed. Consult your healthcare provider if you are pregnant or planning to become pregnant.
The safety of Travelit Tablet 50 mg during lactation is not well established. It is recommended to avoid use during breastfeeding unless absolutely necessary and to consult your healthcare provider for alternative options.
In case of acute overdose, symptoms may include severe drowsiness, hallucinations, seizures, and anticholinergic effects. Seek immediate medical attention if an overdose is suspected.
Travelit Tablet 50 mg is contraindicated in individuals with hypersensitivity to the drug or any of its components. It should be avoided in patients with certain pre-existing conditions, such as narrow-angle glaucoma and severe prostatic hypertrophy.
Follow the prescribed dosage and administration instructions. Do not exceed the recommended dose or frequency of use. Consult your healthcare provider for any changes in the treatment regimen.
Store Travelit Tablet 50 mg at room temperature, away from direct light and moisture. Keep the medication out of reach of children and do not use beyond the expiration date.
The volume of distribution for Travelit Tablet 50 mg is approximately 4.5 L/kg, indicating distribution into body tissues.
The elimination half-life of Travelit Tablet 50 mg is approximately 20 hours, supporting its dosing frequency.
The drug is primarily cleared through hepatic metabolism and renal excretion. Clearance is influenced by liver function and overall health status.
See in details version Travelit Tablet 50 mg also Travelit Tablet 50 mg in bangla